ALNY
ALNYLAM PHARMACEUTICALS, INC.Biotechnology · Biotechnology
$231.58 sample
+0.63 (+0.27%) 1D
Market cap
$1.41T
Price as of
2026-10-29
Latest filing
8-K · 2026-10-21
Alerts
8
Price$231.58 -7.33% 3M daily closessample
250.48230.95
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 21SEC
- Oct 13INS
- Oct 07INS
- Sep 30INS
- Sep 21INS
- Sep 15INS
- Sep 04INS
- Aug 26INS
Company facts
SEC EDGAR registration- Name
- ALNYLAM PHARMACEUTICALS, INC.
- Sector
- Biotechnology
- Industry
- Biotechnology
- Smart-money score
- -36sample, -100 to +100
- Reporting currency
- USD
Who is positioning in ALNY
sample- Insiders
- 7 insider transactions over 90 days, net selling, $882.4M
- Congress
- 3 members traded over 90 days
- Institutions · 13F
- 12 funds hold $16.7B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$78.6B +16.3% y/y
Q4 2024Q3 2026
Inventory$47.5B +11.8% y/y
Q4 2024Q3 2026
Accounts receivable$33.7B +9.5% y/y
Q4 2024Q3 2026
Total debt$93.7B +11.5% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $1.29T +3.6% 3M
- Sample peer B
- $1.21T +0.2% 3M
- Sample peer C
- $176.0B +1.9% 3M
- Sample peer D
- $563.7B +13.8% 3M
- Sample peer E
- $1.31T +7.1% 3M